MDC1 counteracts restrained replication fork restart and its loss causes chemoresistance in BRCA1/2-deficient mammary tumors
Martin Liptay(University of Bern), Sven Rottenberg(University of Bern)
Cited by 6
Related Papers
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
|Nature Communications|2024|40
Haploid genetic screens identify genetic vulnerabilities to microtubule‐targeting agents
|Molecular Oncology|2018|27
PARG-deficient tumor cells have an increased dependence on EXO1/FEN1-mediated DNA repair
|The EMBO Journal|2024|23
H2AX promotes replication fork degradation and chemosensitivity in BRCA-deficient tumours
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2